Clinical Trials: Cystic Fibrosis and Bronchiectasis

Our adult Cystic Fibrosis Program is accredited by the Cystic Fibrosis Foundation. We serve over 250 adults with CF and have multi-disciplinary team dedicated to the care of patients with CF.

Please contact our clinic at 214-645-0599 for further information.

We participate in a number of multicenter clinical trials studying novel therapies for the treatment of Cystic Fibrosis and other forms of bronchiectasis. These therapies include anti-inflammatories, anti-infectives, and CFTR modulators in the form of Phase 1, 2 and 3 trials, both outpatient and inpatient.

We are also spearheading prospective clinical trials to understand the impact of natural hormone fluctuation, birth control, and pregnancy on markers of health in Cystic Fibrosis patients that correlate with our bench related studies. 

See listings of these trials in: